These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4665286)

  • 21. A possible feed-back mechanism controlling the biosynthesis of 5-hydroxytryptamine.
    Contractor SF; Jeacock MK
    Biochem Pharmacol; 1967 Oct; 16(10):1981-7. PubMed ID: 5299642
    [No Abstract]   [Full Text] [Related]  

  • 22. (18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.
    Firnau G; Garnett ES; Sourkes TL; Missala K
    Experientia; 1975 Nov; 31(11):1254-5. PubMed ID: 1204761
    [No Abstract]   [Full Text] [Related]  

  • 23. Measurement of aromatic L-amino acid decarboxylase--a technical comment.
    Mackowiak ED; Hare TA; Vogel WH
    Biochem Med; 1972 Dec; 6(6):562-7. PubMed ID: 4640195
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat.
    Bouchard S; Bousquet C; Roberge AG
    J Neurochem; 1981 Sep; 37(3):781-7. PubMed ID: 6974228
    [No Abstract]   [Full Text] [Related]  

  • 25. L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.
    Rivera-Calimlim L; Morgan JP; Dujovne CA; Bianchine JR; Lasagna L
    Biochem Pharmacol; 1971 Nov; 20(11):3051-7. PubMed ID: 5132112
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of catechol structure in the inhibitory effects of D-isomers of amino acids on the decarboxylation of L-5-hydroxytryptophan.
    Shikimi T; Inagaki C; Takaori S
    Experientia; 1978 Sep; 34(9):1188-9. PubMed ID: 309827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
    Gauthier G; Juge O; Birchler A
    Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
    [No Abstract]   [Full Text] [Related]  

  • 28. New pathway for metabolism of dopa.
    O'Leary MH; Baughn RL
    Nature; 1975 Jan; 253(5486):52-3. PubMed ID: 1167399
    [No Abstract]   [Full Text] [Related]  

  • 29. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: assay characteristics and distribution.
    Sims KL; Davis GA; Bloom FE
    J Neurochem; 1973 Feb; 20(2):449-64. PubMed ID: 4540567
    [No Abstract]   [Full Text] [Related]  

  • 31. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
    Bertoldi M; Borri Voltattorni C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gas chromatographic method for measuring DOPA decarboxylase activity in tissues.
    Wong KP; Sandler M
    Clin Chim Acta; 1974 Jan; 50(1):119-28. PubMed ID: 4816435
    [No Abstract]   [Full Text] [Related]  

  • 33. Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets.
    Lindström P
    Biochim Biophys Acta; 1986 Nov; 884(2):276-81. PubMed ID: 3533158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 35. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I; Inagaki C; Araki H; Tanaka C
    Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition-state analogues as inhibitors of L-dopa decarboxylase.
    Brinkworth RI; Iles MM; Iskander MN; Andrews PR
    Int J Biochem; 1988; 20(11):1273-9. PubMed ID: 3248681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambivalence on the multiplicity of mammalian aromatic L-amino acid decarboxylase.
    Ebadi M; Simonneaux V
    Adv Exp Med Biol; 1991; 294():115-25. PubMed ID: 1772061
    [No Abstract]   [Full Text] [Related]  

  • 39. Dye-sensitized photo-oxidation of pig kidney Dopa decarboxylase.
    Pasqua A; Dominici P; Murgia SM; Poletti A; Borri Voltattorni C
    Biochem Int; 1984 Oct; 9(4):437-46. PubMed ID: 6517952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
    Orosz D; Cohen G
    Eur J Pharmacol; 1987 Apr; 136(3):441-4. PubMed ID: 3111867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.